49 related articles for article (PubMed ID: 9345304)
1. A conditional version of the Ets transcription factor Erm by fusion to the ligand binding domain of the oestrogen receptor.
Pelczar H; Albagli O; Chotteau-Lelievre A; Damour I; de Launoit Y
Biochem Biophys Res Commun; 1997 Oct; 239(1):252-6. PubMed ID: 9345304
[TBL] [Abstract][Full Text] [Related]
2. The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA.
Janknecht R; Monté D; Baert JL; de Launoit Y
Oncogene; 1996 Oct; 13(8):1745-54. PubMed ID: 8895521
[TBL] [Abstract][Full Text] [Related]
3. Two functionally distinct domains responsible for transactivation by the Ets family member ERM.
Laget MP; Defossez PA; Albagli O; Baert JL; Dewitte F; Stehelin D; de Launoit Y
Oncogene; 1996 Mar; 12(6):1325-36. PubMed ID: 8649835
[TBL] [Abstract][Full Text] [Related]
4. The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors.
de Launoit Y; Audette M; Pelczar H; Plaza S; Baert JL
Oncogene; 1998 Apr; 16(16):2065-73. PubMed ID: 9572487
[TBL] [Abstract][Full Text] [Related]
5. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation and transformation by chimaeric Fos-estrogen receptor proteins: altered properties as a consequence of gene fusion.
Schuermann M; Hennig G; Müller R
Oncogene; 1993 Oct; 8(10):2781-90. PubMed ID: 8378087
[TBL] [Abstract][Full Text] [Related]
7. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.
Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
[TBL] [Abstract][Full Text] [Related]
8. GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors.
Kitajima K; Masuhara M; Era T; Enver T; Nakano T
EMBO J; 2002 Jun; 21(12):3060-9. PubMed ID: 12065419
[TBL] [Abstract][Full Text] [Related]
9. A versatile framework for the design of ligand-dependent, transgene-specific transcription factors.
Xu L; Zerby D; Huang Y; Ji H; Nyanguile OF; de los Angeles JE; Kadan MJ
Mol Ther; 2001 Feb; 3(2):262-73. PubMed ID: 11237684
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
[TBL] [Abstract][Full Text] [Related]
11. Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes.
Huang J; Li X; Yi P; Hilf R; Bambara RA; Muyan M
Mol Cell Endocrinol; 2004 Apr; 218(1-2):65-78. PubMed ID: 15130512
[TBL] [Abstract][Full Text] [Related]
12. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
Chang CH; Scott GK; Baldwin MA; Benz CC
Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
[TBL] [Abstract][Full Text] [Related]
13. Genomic organization of the human ERM (ETV5) gene, a PEA3 group member of ETS transcription factors.
Monté D; Coutte L; Dewitte F; Defossez PA; Le Coniat M; Stéhelin D; Berger R; de Launoit Y
Genomics; 1996 Jul; 35(1):236-40. PubMed ID: 8661127
[TBL] [Abstract][Full Text] [Related]
14. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation.
Zurovec M; Petrenko O; Roll R; Enrietto PJ
Oncogene; 1998 Jun; 16(24):3133-42. PubMed ID: 9671392
[TBL] [Abstract][Full Text] [Related]
15. IL-6 promoter is modulated by the 24 kDa FGF-2 isoform fused to the hormone binding domain of the oestrogen receptor.
Delrieu I; Chinestra P; Delassus F; Bayard F; Prats H; Faye JC
Cytokine; 2000 Jul; 12(7):1110-4. PubMed ID: 10880259
[TBL] [Abstract][Full Text] [Related]
16. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor.
Ohtake F; Takeyama K; Matsumoto T; Kitagawa H; Yamamoto Y; Nohara K; Tohyama C; Krust A; Mimura J; Chambon P; Yanagisawa J; Fujii-Kuriyama Y; Kato S
Nature; 2003 May; 423(6939):545-50. PubMed ID: 12774124
[TBL] [Abstract][Full Text] [Related]
17. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.
Schwachtgen JL; Janel N; Barek L; Duterque-Coquillaud M; Ghysdael J; Meyer D; Kerbiriou-Nabias D
Oncogene; 1997 Dec; 15(25):3091-102. PubMed ID: 9444957
[TBL] [Abstract][Full Text] [Related]
18. Interplay between liganded and orphan nuclear receptors controls reproductive pathways.
Métivier R; Le Dréan Y; Salbert G; Pakdel F
Biochem Cell Biol; 2000; 78(3):345-58. PubMed ID: 10949085
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA
J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the N-terminal transactivation domain of ERM modified by SUMO-1.
Lens Z; Dewitte F; Monté D; Baert JL; Bompard C; Sénéchal M; Van Lint C; de Launoit Y; Villeret V; Verger A
Biochem Biophys Res Commun; 2010 Aug; 399(1):104-10. PubMed ID: 20647002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
